Site icon OncologyTube

Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelcaâ„¢ (lurbinectedin) for the Treatment of Metastatic Small Cell Lung Cancer – What are some key takeaways – Jeff Pet…

Jeff Petty, MD Wake Forest Baptist Health discusses Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelcaâ„¢ (lurbinectedin) for the Treatment of Metastatic Small Cell Lung Cancer

Exit mobile version